Tissue Tolerable Plasma (TTP) induces apoptosis in pancreatic cancer cells in vitro and in vivo

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Partecke, Lars I ^a   Evert, Katja ^a   Haugk, Jan ^a   Doering, Friderike ^a   Normann, Lars ^a   Diedrich, Stephan ^a   Weiss, Frank Ulrich ^a   Evert, Matthias ^a   Huebner, Nils O ^a   Guenther, Cristin ^a   Heidecke, Claus D ^a   Kramer, Axel ^a   Bussiahn, René ^b   Weltmann, Klaus Dieter ^b   Pati, Onur ^a   Bender, Claudia ^a   von Bernstorff, Wolfram ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b LEIBNIZ INSTITUTE FOR PLASMA SCIENCE AND TECHNOLOGY   (Germany)

Author keywords

Apoptosis; Pancreatic cancer; Plasma medicine; Tissue tolerable plasma (TTP); TUM CAM Assay

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; FLUORESCEIN ISOTHIOCYANATE; KI 67 ANTIGEN; LIPOCORTIN 5; PROPIDIUM IODIDE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER THERAPY; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NICK END LABELING; NONHUMAN; OUTCOME ASSESSMENT; PANCREAS CANCER; THERAPY EFFECT; TISSUE PREPARATION; TISSUE TOLERABLE PLASMA;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CRYOTHERAPY; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MODELS, BIOLOGICAL; NEOPLASM, RESIDUAL; PANCREATIC NEOPLASMS; PLASMA GASES;

EID: 84867339416     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-473     Document Type: Article

References (27)

1. Siewert JR, Stein HJ, von Rahden BH. Multimodal treatment of gastrointestinal tract tumors: consequences for surgery. World J Surg 2005, 29(8):940-948.
2. Watanabe M, Baba H, Ishioka C, Nishimura Y, Muto M. Recent advances in diagnosis and treatment for malignancies of the gastrointestinal tract. Digestion 2012, 85(2):95-98.
3. Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, Friess H, Schirmacher P, Buchler MW. Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 2008, 15(6):1651-1660.
4. Thomas RM, Ahmad SA. Current concepts in the surgical management of pancreatic cancer. Surg Oncol Clin N Am 2010, 19(2):335-358.
5. Moisan M, Barbeau J, Moreau S, Pelletier J, Tabrizian M, Yahia LH. Low-temperature sterilization using gas plasmas: a review of the experiments and an analysis of the inactivation mechanisms. Int J Pharm 2001, 226(1-2):1-21.
6. Vandamme M, Robert E, Lerondel S, Sarron V, Ries D, Dozias S, Sobilo J, Gosset D, Kieda C, Legrain B, et al. ROS implication in a new antitumor strategy based on non-thermal plasma. Int J Cancer 2012, 130(9):2185-2194.
7. Fridman GFG, Gutsol A, Shekhter AB, Vasilets VN, Fridman A. Applied Plasma Medicine. Plasma Processes Polym 2008, 5(6):503-533.
8. Bender C, Partecke LI, Kindel E, Doring F, Lademann J, Heidecke CD, Kramer A, Hubner NO. The modified HET-CAM as a model for the assessment of the inflammatory response to tissue tolerable plasma. Toxicol In Vitro 2011, 25(2):530-537.
9. Weltmann KD KE, Brandenburg R, Meyer C, Bussiahn R, Wilke C, von Woedtke T. Atmospheric pressure plasma jet for medical therapy: plasma. parameters and risk estimation. Contrib Plasma Phys 2009, 49(9):674-683.
10. Kramer A, Lindequist U, Weltmann KD, Wilke C, Von Woedtke T. Plasma Medicine - its perspective for wound therapy. GMS Krankenhhyg Interdiszip 2008, 3(1):Doc16.
11. Fluhr JW, Sassning S, Lademann O, Darvin ME, Schanzer S, Kramer A, Richter H, Sterry W, Lademann J. In vivo skin treatment with tissue-tolerable plasma influences skin physiology and antioxidant profile in human stratum corneum. Exp Dermatol 2012, 21(2):130-134.
12. Lademann O, Kramer A, Richter H, Patzelt A, Meinke MC, Czaika V, Weltmann KD, Hartmann B, Koch S. Skin disinfection by plasma-tissue interaction: comparison of the effectivity of tissue-tolerable plasma and a standard antiseptic. Skin Pharmacol Physiol 2011, 24(5):284-288.
13. Kramer A, Hübner NO, Assadian O, Below H, Bender C, Bröker B, Ekkernkamp A, Eisenbeiß W, Hammann A, Hartmann B, Heidecke CD, Hinz P, Koban I, Koch S, Kocher T, Lademann J, Lademann O, Lerch MM, Maier S, Matthes M, Müller M, Partecke I, Rändler C, Weltmann KD, Zygmunt M. Chances and perspectives of the plasma medicine by use of Tissue Tolerable Plasma (TTP). GMS Krankenhaushygiene Interdisziplinär 2009, 4(2):1-15.
14. Bender CMR, Kindel E, Kramer A, Lademann J, Weltmann KD, Eisenbeiß W, Hübner NO. The irritation potential of nonthermal atmospheric pressure plasma in the HET-CAM. Plasma Processes Polym 2010, 7(3-4):318-326.
15. Kim JY, Wei Y, Li J, Kim SO. 15-μm-sized single-cellular-level and cell-manipulatable microplasma jet in cancer therapies. Biosens Bioelectron 2010, 26(2):555-559.
16. Morgan RT, Woods LK, Moore GE, Quinn LA, McGavran L, Gordon SG. Human cell line (COLO 357) of metastatic pancreatic adenocarcinoma. Int J Cancer 1980, 25(5):591-598.
17. Partecke LI, Sendler M, Kaeding A, Weiss FU, Mayerle J, Dummer A, Nguyen TD, Albers N, Speerforck S, Lerch MM, et al. A syngeneic orthotopic murine model of pancreatic adenocarcinoma in the C57/BL6 mouse using the Panc02 and 6606PDA cell lines. Eur Surg Res 2011, 47(2):98-107.
18. Marques IJ, Weiss FU, Vlecken DH, Nitsche C, Bakkers J, Lagendijk AK, Partecke LI, Heidecke CD, Lerch MM, Bagowski CP. Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model. BMC Cancer 2009, 9:128.
19. Kim CH, Kwon S, Bahn JH, Lee K, Jun SI, Rack PD, Baek SJ. Effects of atmospheric nonthermal plasma on invasion of colorectal cancer cells. Appl Phys Lett 2010, 96(24):243701.
20. Kim JY, Ballato J, Foy P, Hawkins T, Wei Y, Li J, Kim SO. Apoptosis of lung carcinoma cells induced by a flexible optical fiber-based cold microplasma. Biosens Bioelectron 2011, 28(1):333-338.
21. Keidar M, Walk R, Shashurin A, Srinivasan P, Sandler A, Dasgupta S, Ravi R, Guerrero-Preston R, Trink B. Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy. Br J Cancer 2011, 105(9):1295-1301.
22. Yan X, Xiong Z, Zou F, Zhao S, Lu X, Yang G, He G, Ostrikov K. Plasma-induced Death of HepG2 Cancer cells: Intracellular effects of reactive species. Plasma Processes ans polymers 2012, 9:59-66.
23. Ahn HJ, Kim KI, Kim G, Moon E, Yang SS, Lee JS. Atmospheric-pressure plasma jet induces apoptosis involving mitochondria via generation of free radicals. PLoS One 2011, 6(11):e28154.
24. Vandamme M, Robert E, Pesnel S, Barbosa E, Dozias S, Sobilo J, Lerondel S, Le Pape A, Pouvesle JM. Antitumor effect of plasma treatment on U87 Glioma Xenografts: preliminary results. Plasma Processes ans polymers 2010, 7(3-4):264-273.
25. Westgaard A, Tafjord S, Farstad IN, Cvancarova M, Eide TJ, Mathisen O, Clausen OP, Gladhaug IP. Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor. BMC Cancer 2008, 8:5.
26. Heinrich S, Pestalozzi B, Lesurtel M, Berrevoet F, Laurent S, Delpero JR, Raoul JL, Bachellier P, Dufour P, Moehler M, et al. Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study). BMC Cancer 2011, 11:346.
27. Partecke IL, Kaeding A, Sendler M, Albers N, Kuhn JP, Speerforck S, Roese S, Seubert F, Diedrich S, Kuehn S, et al. In vivo imaging of pancreatic tumours and liver metastases using 7 Tesla MRI in a murine orthotopic pancreatic cancer model and a liver metastases model. BMC Cancer 2011, 11:40.